Assignee
GIGAGEN INC
US·24 granted patents·17 pending applications·52 citations·filing 2012–2025
Top patents by PatentIndex Score
41 records- 0196US9422547B1Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2015·Granted Aug 23, 2016·11 cites·16 claims
- 0295US9738699B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2016·Granted Aug 22, 2017·9 cites·12 claims
- 0394US9695474B2System and methods for massively parallel analysis of nucleic acids in single cellsGIGAGEN INC·Filed 2016·Granted Jul 4, 2017·8 cites·22 claims
- 0492US10329557B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2018·Granted Jun 25, 2019·9 cites·16 claims
- 0592US9926555B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2017·Granted Mar 27, 2018·5 cites·4 claims
- 0689US10689641B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2019·Granted Jun 23, 2020·2 cites·3 claims
- 0787US10787706B2System and methods for massively parallel analysis of nucleic acids in single cellsGIGAGEN INC·Filed 2019·Granted Sep 29, 2020·1 cites·10 claims
- 0887US10465243B2System and methods for massively parallel analysis of nucleic acids in single cellsGIGAGEN INC·Filed 2018·Granted Nov 5, 2019·1 cites·12 claims
- 0985US11053543B2System and methods for massively parallel analysis of nucleic acids in single cellsGIGAGEN INC·Filed 2020·Granted Jul 6, 2021·1 cites·10 claims
- 1085US2023313291A1System and method for massively parallel analysis for nucleic acids in single cellsGIGAGEN INC·Filed 2023·Application pending·0 cites
- 1184US10106789B2System and methods for massively parallel analysis of nucleic acids in single cellsGIGAGEN INC·Filed 2017·Granted Oct 23, 2018·1 cites·16 claims
- 1283US12241178B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2022·Granted Mar 4, 2025·0 cites·12 claims
- 1383US11702765B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2020·Granted Jul 18, 2023·1 cites·10 claims
- 1483US9926554B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2017·Granted Mar 27, 2018·1 cites·5 claims
- 1581US11591652B2System and methods for massively parallel analysis of nucleic acids in single cellsGIGAGEN INC·Filed 2021·Granted Feb 28, 2023·0 cites·14 claims
- 1680US12195880B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2022·Granted Jan 14, 2025·0 cites·16 claims
- 1779US10214740B2Recombinant fusion proteins and libraries from immune cell repertoiresGIGAGEN INC·Filed 2016·Granted Feb 26, 2019·1 cites·5 claims
- 1879US2025179689A1Recombinant Fusion Proteins and Libraries from Immune Cell RepertoiresGIGAGEN INC·Filed 2025·Application pending·0 cites
- 1978US2021292835A1System and methods for massively parallel analysis of nucleic acids in single cellsGIGAGEN INC·Filed 2021·Application pending·0 cites
- 2076US11427933B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2021·Granted Aug 30, 2022·0 cites·13 claims
- 2176US2015344871A1System and Methods for Massively Parallel Analysis of Nucleic Acids in Single CellsGIGAGEN INC·Filed 2014·Application pending·0 cites
- 2275US2026015770A1Recombinant polyclonal proteins targeting covid-19 and methods of use thereofGIGAGEN INC·Filed 2025·Application pending·0 cites
- 2374US11441240B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2019·Granted Sep 13, 2022·0 cites·5 claims
- 2473US11111490B2Systems and methods for massively parallel combinatorial analysis of single cellsGIGAGEN INC·Filed 2019·Granted Sep 7, 2021·0 cites·13 claims
- 2572US12421311B2Anti-CTLA-4 binding proteins and methods of use thereofGIGAGEN INC·Filed 2019·Granted Sep 23, 2025·1 cites·14 claims
- 2671US12404607B2Recombinant polyclonal proteins targeting COVID-19 and methods of use thereofGIGAGEN INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 2770US2017204460A1System and Methods for Massively Parallel Analysis of Nucleic Acids in Single CellsGIGAGEN INC·Filed 2017·Application pending·0 cites
- 2865US2023265171A1Recombinant polyclonal proteins targeting zika and methods of use thereofGIGAGEN INC·Filed 2023·Application pending·0 cites
- 2964US11685779B2Recombinant polyclonal proteins targeting COVID-19 and methods of use thereofGIGAGEN INC·Filed 2021·Granted Jun 27, 2023·0 cites·10 claims
- 3059US11718660B2Recombinant polyclonal proteins targeting Zika and methods of use thereofGIGAGEN INC·Filed 2021·Granted Aug 8, 2023·0 cites·6 claims
- 3156US2025333794A1Hypogammaglobulinemia patient selection for immunoglobulin replacement therapyGIGAGEN INC·Filed 2025·Application pending·0 cites
- 3255US2025289888A1Anti-CTLA-4 Binding Proteins and Methods of Use ThereofGIGAGEN INC·Filed 2022·Application pending·0 cites
- 3351US2015125865A1Methods And Apparatuses For Droplet MixingGIGAGEN INC·Filed 2012·Application pending·0 cites
- 3449US2023265192A1Anti-ctla-4 binding proteins and methods of use thereofGIGAGEN INC·Filed 2021·Application pending·0 cites
- 3549US2016264924A1Methods And Apparatuses For Droplet MixingGIGAGEN INC·Filed 2016·Application pending·0 cites
- 3645US12590386B2Recombinant polyclonal proteins and methods of use thereofGIGAGEN INC·Filed 2020·Granted Mar 31, 2026·0 cites·6 claims
- 3743US2022064302A1Anti-PD-1 Binding Proteins and Methods of Use ThereofGIGAGEN INC·Filed 2019·Application pending·0 cites
- 3843US2022056137A1Anti-PD-L1 Binding Proteins and Methods of Use ThereofGIGAGEN INC·Filed 2019·Application pending·0 cites
- 3941US2015167078A1Methods for antibody and cell therapeutic discoveryGIGAGEN INC·Filed 2014·Application pending·0 cites
- 4039US2015154352A1System and Methods for Genetic Analysis of Mixed Cell PopulationsGIGAGEN INC·Filed 2013·Application pending·0 cites
- 4135US2015031555A1Method for correction of bias in multiplexed amplificationGIGAGEN INC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →